Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction: the EXAMI study.
Flip J P
FJ
Bernink
Leo
L
Timmers
Michaela
M
Diamant
Martijn
M
Scholte
Aernout M
AM
Beek
Otto
O
Kamp
Koen M J
KM
Marques
Robert N
RN
Denham
Weena J Y
WJ
Chen
Pieter A
PA
Doevendans
Albert C
AC
van Rossum
Niels
N
van Royen
Anton J G
AJ
Horrevoets
Yolande
Y
Appelman
D061605:Administration, Intravenous; D000368:Aged; D000077270:Exenatide; D005240:Feasibility Studies; D005260:Female; D005500:Follow-Up Studies; D052216:Glucagon-Like Peptide 1; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000188:drug therapy* / Q000601:surgery; D010455:Peptides / Q000008:administration & dosage*; D062645:Percutaneous Coronary Intervention / Q000379:methods; D016896:Treatment Outcome; D014688:Venoms / Q000008:administration & dosage*
D010455:Peptides; D014688:Venoms; D052216:Glucagon-Like Peptide 1; D000077270:Exenatide